INGENIA THERAPEUTICS

Ingenia Therapeutics provider of undisclosed products and services based in Cambridge, Massachusets.

#SimilarOrganizations #People #More

INGENIA THERAPEUTICS

Founded:
2018-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Total Employee:
1+

Status:
Active

Contact:
(781) 491-9005

Total Funding:
4.71 M USD


Similar Organizations

858-therapeutics-logo

858 Therapeutics

858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology.

gage-cannabis-logo

Gage Cannabis

Gage Cannabis is a craft cannabis brand and operator.

livwell-enlightened-health-logo

LivWell Enlightened Health

LivWell Enlightened Health is a medical cannabis company producing and retailing multi-state cannabis.

Current Employees Featured

sangyeul-han_image

Sangyeul Han
Sangyeul Han Co-Founder and CEO @ Ingenia Therapeutics
Co-Founder and CEO
2018-01-01

Founder


sangyeul-han_image

Sangyeul Han

More informations about "Ingenia Therapeutics"

Ingenia Therapeutics - Crunchbase Company Profile & Funding

Ingenia Therapeutics is a biotechnology company developing a therapeutic antibody candidate to treat multiple diseases, including cancer and inflammatory diseases. It specializes in …See details»

INGENIA Therapeutics

INGENIA Therapeutics is a research-driven biotechnology company. We are committed to the discovery and development of advanced therapeutics for patients afflicted by inflamed and …See details»

INGENIA Therapeutics Company Profile 2024: Valuation, Funding ...

INGENIA Therapeutics General Information Description. Developer of a therapeutic antibody candidate designed for capillary diseases. The company specializes in discovering and …See details»

INGENIA Therapeutics

Sangyeul Han founded INGENIA Therapeutics in 2018. Previously, he worked at Cell Signaling Technology where he led its Antibody Technology and Molecular Biology groups. Before CST, …See details»

Ingenia Therapeutics Inc. - Drug pipelines, Patents, Clinical trials ...

Last update 01 Nov 2024. Ingenia Therapeutics Inc. Startups |See details»

Ingenia Therapeutics - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Nov 30, 2022: Venture Round …See details»

Ingenia Therapeutics - Company Profile - Tracxn

Dec 5, 2024 Ingenia Therapeutics has filed a notice of an exempt offering of securities to raise $25,000,000.00 in New Equity Investment.intelligence360 • Jul 04, 2024 • Ingenia …See details»

INGENIA Therapeutics - LinkedIn

INGENIA Therapeutics | 826 followers on LinkedIn. INGENIA Therapeutics strives to develop antibodies to treat multiple diseases including cancer & inflammatory diseases | INGENIA …See details»

Ingenia Therapeutics Inc. Company Profile - Dun & Bradstreet

Ingenia Therapeutics Inc. Company Profile | Watertown, MA | Competitors, Financials & Contacts - Dun & BradstreetSee details»

Nona Biosciences and INGENIA Therapeutics Enter into …

Oct 13, 2023 About INGENIA Therapeutics INGENIA is a privately held biotechnology company specializing in a proprietary microvasculature protection technology aimed at offering a means …See details»

IGT-512 - Drug Targets, Indications, Patents - Synapse

IGT-512, Initially developed by Ingenia Therapeutics Inc., Now, its global highest R&D status is Discovery, Therapeutic Areas: Neoplasms, Active Indication: Neoplasms, Active Org.: Ingenia …See details»

Nona Biosciences and INGENIA Therapeutics Enter into …

Oct 13, 2023 Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, and INGENIA Therapeutics, a preclinical-stage biotech …See details»

Technology - INGENIA Therapeutics

By modifying endothelial cell signaling, INGENIA technology provides breakthrough vascular therapeutics. Based on our deep understanding of endothelial biology, we found a unique way …See details»

Nona Biosciences and INGENIA Therapeutics Enter into …

CAMBRIDGE, Mass., Oct. 13, 2023 /PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, and INGENIA …See details»

IGT-302 - Drug Targets, Indications, Patents - Synapse - Patsnap

Nov 21, 2024 IGT-302, Initially developed by Ingenia Therapeutics Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Eye Diseases, Active Indication: Glaucoma, …See details»

News - INGENIA Therapeutics

INGENIA Therapeutics & Nona Biosciences Enter into Collaboration Agreement. Oct 19,2023 INGENIA. INGENIA Therapeutics & Mosaic Biosciences present preclinical data. May 02,2022 …See details»

Ingenia Therapeutics | Watertown MA - Facebook

Ingenia Therapeutics, Watertown, Massachusetts. 4 likes. Dedicated to developing breakthrough therapeutics for capillary diseases of high unmet need Ingenia Therapeutics | Watertown MASee details»

IGT-427 - Drug Targets, Indications, Patents - Synapse - Patsnap

Dec 27, 2024 Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»

Inflammatory diseases(Ingenia) - Drug Targets, Indications, Patents ...

Now, its global highest R&D status is Preclinical, Therapeutic Areas: Other Diseases, Active Indication: Inflammation, Active Org.: Ingenia Therapeutics Inc.. Biomedical products DataSee details»

linkstock.net © 2022. All rights reserved